ESMO shared a post on X:
“ESMO Clinical Practice Guideline eUpdate on Oesophageal Cancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- and post-operative chemotherapy is associated with improved survival vs Neoadjuvant Chemoradiotherapy.”